Page last updated: 2024-11-02

phenobarbital and Biliary Tract Cancer

phenobarbital has been researched along with Biliary Tract Cancer in 2 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Olsen, JH1
Schulgen, G1
Boice, JD1
Whysner, J1
Travis, LB1
Williams, GM1
Johnson, FB1
McGee, JO1
Duran, ME1
Roncero, V1
Gómez, L1
Masot, AJ1
Redondo, E1
Gázquez, A1

Other Studies

2 other studies available for phenobarbital and Biliary Tract Cancer

ArticleYear
Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma.
    Cancer research, 1995, Jan-15, Volume: 55, Issue:2

    Topics: Aged; Aged, 80 and over; Biliary Tract Neoplasms; Case-Control Studies; Epilepsy; Female; Humans; Li

1995
Experimental induction of biliary cystadenoma in rats: a morphological study.
    Histology and histopathology, 1992, Volume: 7, Issue:4

    Topics: Animals; Biliary Tract Neoplasms; Cystadenoma; Diethylnitrosamine; Female; Liver; Male; Microscopy,

1992